FDA
-
-
-
-
-
-
-
Ainos Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Ainos (AIMD) to Initiate Taiwan Clinical Study for VELDONA
-
-
-
-
-
-
-
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
-
-
-
-
-
-
-
Ainos Reports Unaudited Third Quarter 2022 Financial Results
-
-
-
-
-
-
-
Ainos Announces Master Services Agreement with Swiss Pharmaceutical, Ltd. for Drug Testing, Manufacturing, and Packaging for its VELDONA Product Candidates
-
-
-
322,897 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

